$BRZE stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $4,921,573 of trading volume.
Here is what we see in our data on $BRZE (you can track the company live on Quiver's $BRZE stock page):
$BRZE Insider Trading Activity
$BRZE insiders have traded $BRZE stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $BRZE stock by insiders over the last 6 months:
- WILLIAM MAGNUSON (Chief Executive Officer) has made 0 purchases and 2 sales selling 53,111 shares for an estimated $1,158,406.
- ASTHA MALIK (Chief Business Officer) has made 0 purchases and 3 sales selling 31,641 shares for an estimated $725,695.
- ISABELLE WINKLES (Chief Financial Officer) has made 0 purchases and 2 sales selling 24,954 shares for an estimated $543,088.
- PANKAJ MALIK (Chief Accounting Officer) has made 0 purchases and 4 sales selling 16,251 shares for an estimated $480,947.
- SUSAN WISEMAN (General Counsel) has made 0 purchases and 5 sales selling 19,860 shares for an estimated $437,221.
- JONATHAN HYMAN (Chief Technology Officer) has made 0 purchases and 2 sales selling 17,180 shares for an estimated $385,908.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BRZE Hedge Fund Activity
We have seen 176 institutional investors add shares of $BRZE stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 2,790,422 shares (+935.7%) to their portfolio in Q4 2025, for an estimated $95,683,570
- ALYESKA INVESTMENT GROUP, L.P. added 1,801,019 shares (+592.4%) to their portfolio in Q4 2025, for an estimated $61,756,941
- CADIAN CAPITAL MANAGEMENT, LP removed 1,763,108 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $60,456,973
- WELLINGTON MANAGEMENT GROUP LLP removed 1,116,335 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $31,748,567
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 1,017,288 shares (-37.8%) from their portfolio in Q4 2025, for an estimated $34,882,805
- DEUTSCHE BANK AG\ removed 992,435 shares (-60.2%) from their portfolio in Q4 2025, for an estimated $34,030,596
- VANGUARD GROUP INC added 892,635 shares (+10.0%) to their portfolio in Q4 2025, for an estimated $30,608,454
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BRZE Analyst Ratings
Wall Street analysts have issued reports on $BRZE in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/03/2026
- Needham issued a "Buy" rating on 01/14/2026
- BTIG issued a "Buy" rating on 12/17/2025
- Barclays issued a "Overweight" rating on 12/10/2025
- Mizuho issued a "Outperform" rating on 12/10/2025
- Wells Fargo issued a "Overweight" rating on 12/10/2025
- Citigroup issued a "Buy" rating on 12/10/2025
To track analyst ratings and price targets for $BRZE, check out Quiver Quantitative's $BRZE forecast page.
$BRZE Price Targets
Multiple analysts have issued price targets for $BRZE recently. We have seen 17 analysts offer price targets for $BRZE in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Hannah Rudoff from Piper Sandler set a target price of $30.0 on 02/03/2026
- Gabriela Borges from Goldman Sachs set a target price of $45.0 on 01/28/2026
- Scott Berg from Needham set a target price of $50.0 on 01/14/2026
- Allan Verkhovski from BTIG set a target price of $45.0 on 12/17/2025
- Ryan Macwilliams from Wells Fargo set a target price of $45.0 on 12/10/2025
- Patrick Walravens from Citizens set a target price of $68.0 on 12/10/2025
- Matthew Vanvliet from Cantor Fitzgerald set a target price of $38.0 on 12/10/2025
You can track data on $BRZE on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
